Literature DB >> 24985157

The higher prevalence of non-right handers among patients with restless leg syndrome.

Shadi Ghourchian1, Parviz Bahrami.   

Abstract

Restless leg syndrome (RLS) is a common disorder described as an urge to move the legs. Dopamine, the main neuro-transmitter in the pathophysiology of RLS, is likely related to the development of brain laterality and human handedness. We aimed to compare the prevalence of RLS in right and non-right handers. A checklist including Edinburgh questioner for handedness, questions for RLS diagnosis and basic characteristics was filled out by a sample of population. The exclusion criteria included prolonged use of dopaminergic or psychologic drugs and having diseases with similar symptoms to RLS. The frequency of non-right handers in RLS patients was compared with the controls by Chi square test. P value less than 0.05 was considered significant. 164 persons were divided into RLS patients (69) and non-RLS controls (95). There was no significant difference between demographic characteristics. The prevalence of non-right handers in RLS patients was significantly more than non-RLS controls (P: 0.03). Our finding regarding the higher prevalence of non-right handers in RLS patients needs more justifications based on neuroscientists' guides. RLS as a disease in which dopaminergic system involves is highly assumed to be linked with handedness. This is just a hypothesis that impaired modulation of immune system in left handers may be accompanied with lower dopamine levels in RLS.

Entities:  

Mesh:

Year:  2014        PMID: 24985157     DOI: 10.1007/s10072-014-1860-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  33 in total

1.  Anomalous brain dominance and the immune system: do left-handers have specific immunological patterns?

Authors:  Charis Lengen; Marianne Regard; Helen Joller; Theodor Landis; Patrice Lalive
Journal:  Brain Cogn       Date:  2008-08-30       Impact factor: 2.310

2.  The prevalence of iron deficiency anaemia in female medical students in Tehran.

Authors:  S Shams; H Asheri; A Kianmehr; V Ziaee; L Koochakzadeh; M Monajemzadeh; M Nouri; H Irani; N Gholami
Journal:  Singapore Med J       Date:  2010-02       Impact factor: 1.858

3.  Idiopathic restless legs syndrome: abnormalities in central somatosensory processing.

Authors:  Jörn Schattschneider; Andre Bode; Gunnar Wasner; Andreas Binder; Günther Deuschl; Ralf Baron
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

4.  Restless legs syndrome.

Authors:  Max Bayard; Thomas Avonda; James Wadzinski
Journal:  Am Fam Physician       Date:  2008-07-15       Impact factor: 3.292

5.  Opposite turning behavior in right-handers and non-right-handers suggests a link between handedness and cerebral dopamine asymmetries.

Authors:  C Mohr; T Landis; H S Bracha; P Brugger
Journal:  Behav Neurosci       Date:  2003-12       Impact factor: 1.912

6.  Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence.

Authors:  Tasneem Peeraully; Eng-King Tan
Journal:  Transl Neurodegener       Date:  2012-02-27       Impact factor: 8.014

Review 7.  Restless legs syndrome: pathophysiology, diagnosis and treatment.

Authors:  Pankaj Satija; William G Ondo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  Prevalence and impact of restless legs syndrome in pregnancy.

Authors:  Michal Minar; Hana Habanova; Igor Rusnak; Karol Planck; Peter Valkovic
Journal:  Neuro Endocrinol Lett       Date:  2013       Impact factor: 0.765

9.  The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal.

Authors:  Christopher J Earley; Richard P Allen; James R Connor; Luigi Ferrucci; Juan Troncoso
Journal:  Sleep Med       Date:  2009-03-23       Impact factor: 3.492

10.  Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.

Authors:  Wei Zhao; Yan Huang; Zhan Liu; Bei-Bei Cao; Yu-Ping Peng; Yi-Hua Qiu
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.